Chen Qiang, Su Hong, Yu Xiuqiong, Chen Yingzhong, Ding Xunshi, Xiong Bo, Wang Chunbin, Xia Long, Ye Tao, Lan Kai, Hou Jun, Xiong Shiqiang, Cai Lin
From Department of Cardiology, The Third People's Hospital of Chengdu, Affiliated Hospital of Southwest Jiaotong University, Chengdu Cardiovascular Disease Research Institute, Chengdu 610014, Sichuan, China.
From Department of Cardiology, The Third People's Hospital of Chengdu, Affiliated Hospital of Southwest Jiaotong University, Chengdu Cardiovascular Disease Research Institute, Chengdu 610014, Sichuan, China.
Hellenic J Cardiol. 2023 Mar-Apr;70:36-45. doi: 10.1016/j.hjc.2022.12.012. Epub 2022 Dec 28.
The Global Registry of Acute Coronary Events (GRACE) score is a powerful tool used to predict in-hospital mortality after acute myocardial infarction (AMI) and does not include a glycometabolism-related index. We investigated whether the addition of the stress hyperglycemia ratio (SHR) provides incremental prognostic value in addition to the GRACE score.
A retrospective cohort of 613 AMI patients was enrolled in the present analyses. The patients were stratified according to the primary endpoint (in-hospital mortality) and the tertiles of the SHR.
During hospitalization, 40 patients reached the primary endpoint, which was more frequently observed in patients with a higher SHR. The SHR, but not admission blood glucose (ABG), adjusted for the GRACE score independently predicted in-hospital mortality [odds ratio 2.5861; 95% confidence interval (CI), 1.3910-4.8080; P = 0.0027]. The adjustment of the GRACE score by the SHR improved the predictive ability for in-hospital death (an increase in the C-statistic value from 0.787 to 0.814; net reclassification improvement, 0.6717, 95% CI 0.3665-0.977, P < 0.01; integrated discrimination improvement, 0.028, 95% CI 0.0066-0.0493, P = 0.01028). The likelihood ratio test showed that the SHR significantly improved the prognostic models, including the GRACE score. Adding the SHR to the GRACE score presented a larger net benefit across the range of in-hospital mortality risk than the GRACE score alone.
The SHR, but not the ABG, is an independent predictor of in-hospital mortality after AMI even after adjusting for the GRACE score. The SHR improves the predictability and clinical usefulness of prognostic models containing the GRACE score.
全球急性冠状动脉事件注册研究(GRACE)评分是预测急性心肌梗死(AMI)后院内死亡率的有力工具,且不包括糖代谢相关指标。我们研究了除GRACE评分外,加入应激性高血糖比值(SHR)是否能提供额外的预后价值。
本分析纳入了613例AMI患者的回顾性队列。根据主要终点(院内死亡率)和SHR三分位数对患者进行分层。
住院期间,40例患者达到主要终点,在SHR较高的患者中更常见。经GRACE评分调整后,SHR而非入院血糖(ABG)可独立预测院内死亡率[比值比2.5861;95%置信区间(CI),1.3910 - 4.8080;P = 0.0027]。用SHR调整GRACE评分可提高院内死亡的预测能力(C统计值从0.787增加到0.814;净重新分类改善,0.6717,95% CI 0.3665 - 0.977,P < 0.01;综合判别改善,0.028,95% CI 0.0066 - 0.0493,P = 0.01028)。似然比检验表明,SHR显著改善了包括GRACE评分在内的预后模型。在整个院内死亡风险范围内,将SHR加入GRACE评分比单独使用GRACE评分带来更大的净效益。
即使在调整GRACE评分后,SHR而非ABG仍是AMI后院内死亡率的独立预测因素。SHR提高了包含GRACE评分的预后模型的预测性和临床实用性。